AUSTIN, Texas, Aug. 9, 2017 /PRNewswire/ -- Zilliant, a leading AI-driven SaaS platform for maximizing the lifetime value of B2B customer relationships, today announced the first stop on its Zilliant IQ Event Series: Dallas, Texas on Wednesday, August 23 at the Stoneleigh Hotel.
The B2B market grows more competitive every day, making it increasingly difficult for B2B manufacturers and distributors to hit their numbers. Higher customer churn, increased margin and pricing pressure, and non-traditional competitors are a few factors that impact business performance.
This complimentary, half-day workshop offers event attendees the opportunity to network with peers and discuss tactical steps to get started, including:
- How to uncover additional revenue opportunities for existing customers
- How to provide real-time, actionable guidance to their sales team
- How to reduce customer churn rates
"At our annual customer event in April, attendees overwhelmingly enjoyed the peer-to-peer discussion facilitated at the event, and the opportunity to uncover new paths to revenue," said Zilliant Chief Marketing Officer Maria Carballosa. "That inspired us to facilitate more rich discussions across the nation. The Zilliant IQ Event Series will bring B2B business leaders together in key markets to help them unlock their sales and pricing potential."
Additional stops on the Zilliant IQ Event Series include: Chicago, Minneapolis, Atlanta and Houston. Learn more about the event and access the agenda here.
Zilliant offers the only AI-based SaaS platform enabling B2B companies to grow share and profits while maximizing customer lifetime value. The company's advanced intelligence is delivered seamlessly through the Zilliant IQ™ platform, which is integrated within existing field sales workflows, CRM applications and eCommerce channels, to inform pricing and sales decisions and increase the value of every B2B customer interaction. Learn more about how Zilliant helps maximize the lifetime value of B2B customer relationships at www.zilliant.com.